IOCB-TTO at Bio International Convention (BIO) 2016

15.2.2016

IOCB-TTO at Bio International Convention (BIO) 2016 – IOCB-TTO will attend and present IOCB technologies at the Bio International Convention in San Francisco, CA June 6-9, 2016

1st ever BioSpot conference in Prague

15.1.2016

1st Annual BioSpot conference to be hold at the DOX Gallery in Prague on February 24th, 2016. IOCB-TTO will be participating with three technologies.

IOCB TTO at BioVaria 2016

14.1.2016

IOCB TTO became a partner of Asceion GmbH for BioVaria 2016 conference organzation. The event will be held May 17th in Munich, Germany

Collaboration of IOCB Prague and Johns Hopkins Medicine

8.7.2015

IOCB Prague have entered into a five-year drug discovery research agreement with Johns Hopkins Medicine.

ADVANCES IN DRUG DISCOVERY – Prague Summer School organized by IOCB

10.3.2015

2nd year of the Prague Summer School

ADVANCES IN DRUG DISCOVERY
NOVEL APPROACHES IN DRUG DESIGN AND DEVELOPMENT

PRAGUE, CZECH REPUBLIC, Aug 31st – Sep 4th 2015

IOCB TTO at BioVaria 2015

3.3.2015

IOCB TTO became a partner of Asceion GmbH for BioVaria 2015 conference organzation. The event took place on May 11, 2015, in Munich. Five recent technologies from IOCB TTO portfolio will be presented there!

Awarded Patents 2014

23.2.2015

IOCB TTO team takes care of  IOCB patent portfolio and manages IOCB patents exploitation. Last year was very rich for new inventions. In conclusion, more than 10 patent applications were filed in 2014. Furthermore, 8 patents filed in previus years were awarded.  

Where to meet us in 2014

3.11.2014

Check this post to see where you could meet IOCB TTO in 2014 !

Patent awarded:

14.4.2014

Normuramyl glycopeptide compounds – a patent in collaboration with VRI, ImuThes and other co-authors.

CEO in Headlines

11.3.2014

CEO of IOCB TTO, prof. Martin Fusek and his interview in the Ekonom journal